Global Marine Biomedicine

Marine Biomedicine Comprehensive Study by Type (Marine Animal, Marine Plant), Application (Analgesic, Anticancer, Anti-inflammatory, Antimalarial, Antimicrobial, Bone grafting, Health Care Products), Product (Pharmaceuticals (Ara-A (acyclovir), Ara-C)), Molecular Probes(Manoalide, Okadaic acid), Enzymes (DNA polymerase, Formulaid), Pigment (Phycoerythrin), Cosmetic additives(Resilience)), Source (Marine sponge, Bioluminescent, Microbes, Gorgonians, Soft, Hard corals seaweed) Players and Region - Global Market Outlook to 2026

Marine Biomedicine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Marine Biomedicine Market Overview:
Over the past few years, marine biomedicine addresses the wide variety of marine drug discovery and research activities finding biological samples to clinical trials. Marine biomedicine investigates the mutual relations of creatures and their marine environment using modern molecular, biochemical, and cell biological techniques. Emphasis is put on aspects of human health and illness. It is a source for new therapeutically useful compounds, from the early-stage drug discovery perspective of academia and the clinical therapy development perspective of the industry. Additionally, Marine Biomedicine is inviting contributions to new advances in marine biotechnology, pharmacology, chemical ecology, synthetic biology, and genomics approaches related to the discovery of therapeutically relevant marine natural products.

Growth Drivers
  • Growing usage of marine product in cosmetics, and Pharma industries

Market Trends
  • Development of new entrepreneurial companies

Roadblocks
  • Lack of research in marine is restraining the growth of the marine Biomedicine

Opportunities
  • Discovery of new bioproducts with applications in medicine

Challenges
  • Lack of R&D investment in Biomedicine


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Marinova (Australia), New England Biolabs (United States), Seppic (France), GlycoMar (United Kingdom), Nofima (Norway), Aker BioMarine (Norway) and Aquapharm (United Kingdom). Analyst at AMA Research see United Kingdom Players to retain maximum share of Global Marine Biomedicine market by 2026. Considering Market by Product, the sub-segment i.e. Pharmaceuticals (Ara-A (acyclovir), Ara-C)) will boost the Marine Biomedicine market. Considering Market by Source, the sub-segment i.e. Marine sponge will boost the Marine Biomedicine market.

What Can be Explored with the Marine Biomedicine Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Marine Biomedicine Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Marine Biomedicine
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Marine Biomedicine market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Marine Biomedicine market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Marine Biomedicine Manufacturer, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Marine Animal
  • Marine Plant
By Application
  • Analgesic
  • Anticancer
  • Anti-inflammatory
  • Antimalarial
  • Antimicrobial
  • Bone grafting
  • Health Care Products
By Product
  • Pharmaceuticals (Ara-A (acyclovir), Ara-C))
  • Molecular Probes(Manoalide, Okadaic acid)
  • Enzymes (DNA polymerase, Formulaid)
  • Pigment (Phycoerythrin)
  • Cosmetic additives(Resilience)

By Source
  • Marine sponge
  • Bioluminescent
  • Microbes
  • Gorgonians
  • Soft
  • Hard corals seaweed

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing usage of marine product in cosmetics, and Pharma industries
    • 3.3. Market Challenges
      • 3.3.1. Lack of R&D investment in Biomedicine
    • 3.4. Market Trends
      • 3.4.1. Development of new entrepreneurial companies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Marine Biomedicine, by Type, Application, Product, Source and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Marine Biomedicine (Value)
      • 5.2.1. Global Marine Biomedicine by: Type (Value)
        • 5.2.1.1. Marine Animal
        • 5.2.1.2. Marine Plant
      • 5.2.2. Global Marine Biomedicine by: Application (Value)
        • 5.2.2.1. Analgesic
        • 5.2.2.2. Anticancer
        • 5.2.2.3. Anti-inflammatory
        • 5.2.2.4. Antimalarial
        • 5.2.2.5. Antimicrobial
        • 5.2.2.6. Bone grafting
        • 5.2.2.7. Health Care Products
      • 5.2.3. Global Marine Biomedicine by: Product (Value)
        • 5.2.3.1. Pharmaceuticals (Ara-A (acyclovir), Ara-C))
        • 5.2.3.2. Molecular Probes(Manoalide, Okadaic acid)
        • 5.2.3.3. Enzymes (DNA polymerase, Formulaid)
        • 5.2.3.4. Pigment (Phycoerythrin)
        • 5.2.3.5. Cosmetic additives(Resilience)
      • 5.2.4. Global Marine Biomedicine by: Source (Value)
        • 5.2.4.1. Marine sponge
        • 5.2.4.2. Bioluminescent
        • 5.2.4.3. Microbes
        • 5.2.4.4. Gorgonians
        • 5.2.4.5. Soft
        • 5.2.4.6. Hard corals seaweed
      • 5.2.5. Global Marine Biomedicine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Marine Biomedicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Marinova (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. New England Biolabs (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Seppic (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlycoMar (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nofima (Norway)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aker BioMarine (Norway)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Aquapharm (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Marine Biomedicine Sale, by Type, Application, Product, Source and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Marine Biomedicine (Value)
      • 7.2.1. Global Marine Biomedicine by: Type (Value)
        • 7.2.1.1. Marine Animal
        • 7.2.1.2. Marine Plant
      • 7.2.2. Global Marine Biomedicine by: Application (Value)
        • 7.2.2.1. Analgesic
        • 7.2.2.2. Anticancer
        • 7.2.2.3. Anti-inflammatory
        • 7.2.2.4. Antimalarial
        • 7.2.2.5. Antimicrobial
        • 7.2.2.6. Bone grafting
        • 7.2.2.7. Health Care Products
      • 7.2.3. Global Marine Biomedicine by: Product (Value)
        • 7.2.3.1. Pharmaceuticals (Ara-A (acyclovir), Ara-C))
        • 7.2.3.2. Molecular Probes(Manoalide, Okadaic acid)
        • 7.2.3.3. Enzymes (DNA polymerase, Formulaid)
        • 7.2.3.4. Pigment (Phycoerythrin)
        • 7.2.3.5. Cosmetic additives(Resilience)
      • 7.2.4. Global Marine Biomedicine by: Source (Value)
        • 7.2.4.1. Marine sponge
        • 7.2.4.2. Bioluminescent
        • 7.2.4.3. Microbes
        • 7.2.4.4. Gorgonians
        • 7.2.4.5. Soft
        • 7.2.4.6. Hard corals seaweed
      • 7.2.5. Global Marine Biomedicine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Marine Biomedicine: by Type(USD Million)
  • Table 2. Marine Biomedicine Marine Animal , by Region USD Million (2015-2020)
  • Table 3. Marine Biomedicine Marine Plant , by Region USD Million (2015-2020)
  • Table 4. Marine Biomedicine: by Application(USD Million)
  • Table 5. Marine Biomedicine Analgesic , by Region USD Million (2015-2020)
  • Table 6. Marine Biomedicine Anticancer , by Region USD Million (2015-2020)
  • Table 7. Marine Biomedicine Anti-inflammatory , by Region USD Million (2015-2020)
  • Table 8. Marine Biomedicine Antimalarial , by Region USD Million (2015-2020)
  • Table 9. Marine Biomedicine Antimicrobial , by Region USD Million (2015-2020)
  • Table 10. Marine Biomedicine Bone grafting , by Region USD Million (2015-2020)
  • Table 11. Marine Biomedicine Health Care Products , by Region USD Million (2015-2020)
  • Table 12. Marine Biomedicine: by Product(USD Million)
  • Table 13. Marine Biomedicine Pharmaceuticals (Ara-A (acyclovir), Ara-C)) , by Region USD Million (2015-2020)
  • Table 14. Marine Biomedicine Molecular Probes(Manoalide, Okadaic acid) , by Region USD Million (2015-2020)
  • Table 15. Marine Biomedicine Enzymes (DNA polymerase, Formulaid) , by Region USD Million (2015-2020)
  • Table 16. Marine Biomedicine Pigment (Phycoerythrin) , by Region USD Million (2015-2020)
  • Table 17. Marine Biomedicine Cosmetic additives(Resilience) , by Region USD Million (2015-2020)
  • Table 18. Marine Biomedicine: by Source(USD Million)
  • Table 19. Marine Biomedicine Marine sponge , by Region USD Million (2015-2020)
  • Table 20. Marine Biomedicine Bioluminescent , by Region USD Million (2015-2020)
  • Table 21. Marine Biomedicine Microbes , by Region USD Million (2015-2020)
  • Table 22. Marine Biomedicine Gorgonians , by Region USD Million (2015-2020)
  • Table 23. Marine Biomedicine Soft , by Region USD Million (2015-2020)
  • Table 24. Marine Biomedicine Hard corals seaweed , by Region USD Million (2015-2020)
  • Table 25. South America Marine Biomedicine, by Country USD Million (2015-2020)
  • Table 26. South America Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 27. South America Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 28. South America Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 29. South America Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 30. Brazil Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 31. Brazil Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 32. Brazil Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 33. Brazil Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 34. Argentina Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 35. Argentina Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 36. Argentina Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 37. Argentina Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 38. Rest of South America Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 39. Rest of South America Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 40. Rest of South America Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 41. Rest of South America Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 42. Asia Pacific Marine Biomedicine, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 44. Asia Pacific Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 45. Asia Pacific Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 46. Asia Pacific Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 47. China Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 48. China Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 49. China Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 50. China Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 51. Japan Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 52. Japan Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 53. Japan Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 54. Japan Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 55. India Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 56. India Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 57. India Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 58. India Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 59. South Korea Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 60. South Korea Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 61. South Korea Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 62. South Korea Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 63. Taiwan Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 64. Taiwan Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 65. Taiwan Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 66. Taiwan Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 67. Australia Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 68. Australia Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 69. Australia Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 70. Australia Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 75. Europe Marine Biomedicine, by Country USD Million (2015-2020)
  • Table 76. Europe Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 77. Europe Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 78. Europe Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 79. Europe Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 80. Germany Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 81. Germany Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 82. Germany Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 83. Germany Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 84. France Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 85. France Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 86. France Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 87. France Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 88. Italy Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 89. Italy Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 90. Italy Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 91. Italy Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 92. United Kingdom Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 93. United Kingdom Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 94. United Kingdom Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 95. United Kingdom Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 96. Netherlands Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 97. Netherlands Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 98. Netherlands Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 99. Netherlands Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 100. Rest of Europe Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 101. Rest of Europe Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 102. Rest of Europe Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 103. Rest of Europe Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 104. MEA Marine Biomedicine, by Country USD Million (2015-2020)
  • Table 105. MEA Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 106. MEA Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 107. MEA Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 108. MEA Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 109. Middle East Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 110. Middle East Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 111. Middle East Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 112. Middle East Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 113. Africa Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 114. Africa Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 115. Africa Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 116. Africa Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 117. North America Marine Biomedicine, by Country USD Million (2015-2020)
  • Table 118. North America Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 119. North America Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 120. North America Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 121. North America Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 122. United States Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 123. United States Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 124. United States Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 125. United States Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 126. Canada Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 127. Canada Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 128. Canada Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 129. Canada Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 130. Mexico Marine Biomedicine, by Type USD Million (2015-2020)
  • Table 131. Mexico Marine Biomedicine, by Application USD Million (2015-2020)
  • Table 132. Mexico Marine Biomedicine, by Product USD Million (2015-2020)
  • Table 133. Mexico Marine Biomedicine, by Source USD Million (2015-2020)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Marine Biomedicine: by Type(USD Million)
  • Table 142. Marine Biomedicine Marine Animal , by Region USD Million (2021-2026)
  • Table 143. Marine Biomedicine Marine Plant , by Region USD Million (2021-2026)
  • Table 144. Marine Biomedicine: by Application(USD Million)
  • Table 145. Marine Biomedicine Analgesic , by Region USD Million (2021-2026)
  • Table 146. Marine Biomedicine Anticancer , by Region USD Million (2021-2026)
  • Table 147. Marine Biomedicine Anti-inflammatory , by Region USD Million (2021-2026)
  • Table 148. Marine Biomedicine Antimalarial , by Region USD Million (2021-2026)
  • Table 149. Marine Biomedicine Antimicrobial , by Region USD Million (2021-2026)
  • Table 150. Marine Biomedicine Bone grafting , by Region USD Million (2021-2026)
  • Table 151. Marine Biomedicine Health Care Products , by Region USD Million (2021-2026)
  • Table 152. Marine Biomedicine: by Product(USD Million)
  • Table 153. Marine Biomedicine Pharmaceuticals (Ara-A (acyclovir), Ara-C)) , by Region USD Million (2021-2026)
  • Table 154. Marine Biomedicine Molecular Probes(Manoalide, Okadaic acid) , by Region USD Million (2021-2026)
  • Table 155. Marine Biomedicine Enzymes (DNA polymerase, Formulaid) , by Region USD Million (2021-2026)
  • Table 156. Marine Biomedicine Pigment (Phycoerythrin) , by Region USD Million (2021-2026)
  • Table 157. Marine Biomedicine Cosmetic additives(Resilience) , by Region USD Million (2021-2026)
  • Table 158. Marine Biomedicine: by Source(USD Million)
  • Table 159. Marine Biomedicine Marine sponge , by Region USD Million (2021-2026)
  • Table 160. Marine Biomedicine Bioluminescent , by Region USD Million (2021-2026)
  • Table 161. Marine Biomedicine Microbes , by Region USD Million (2021-2026)
  • Table 162. Marine Biomedicine Gorgonians , by Region USD Million (2021-2026)
  • Table 163. Marine Biomedicine Soft , by Region USD Million (2021-2026)
  • Table 164. Marine Biomedicine Hard corals seaweed , by Region USD Million (2021-2026)
  • Table 165. South America Marine Biomedicine, by Country USD Million (2021-2026)
  • Table 166. South America Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 167. South America Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 168. South America Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 169. South America Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 170. Brazil Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 171. Brazil Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 172. Brazil Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 173. Brazil Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 174. Argentina Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 175. Argentina Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 176. Argentina Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 177. Argentina Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 178. Rest of South America Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 179. Rest of South America Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 180. Rest of South America Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 181. Rest of South America Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 182. Asia Pacific Marine Biomedicine, by Country USD Million (2021-2026)
  • Table 183. Asia Pacific Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 184. Asia Pacific Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 185. Asia Pacific Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 186. Asia Pacific Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 187. China Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 188. China Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 189. China Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 190. China Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 191. Japan Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 192. Japan Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 193. Japan Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 194. Japan Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 195. India Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 196. India Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 197. India Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 198. India Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 199. South Korea Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 200. South Korea Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 201. South Korea Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 202. South Korea Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 203. Taiwan Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 204. Taiwan Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 205. Taiwan Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 206. Taiwan Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 207. Australia Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 208. Australia Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 209. Australia Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 210. Australia Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 215. Europe Marine Biomedicine, by Country USD Million (2021-2026)
  • Table 216. Europe Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 217. Europe Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 218. Europe Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 219. Europe Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 220. Germany Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 221. Germany Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 222. Germany Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 223. Germany Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 224. France Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 225. France Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 226. France Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 227. France Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 228. Italy Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 229. Italy Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 230. Italy Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 231. Italy Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 232. United Kingdom Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 233. United Kingdom Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 234. United Kingdom Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 235. United Kingdom Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 236. Netherlands Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 237. Netherlands Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 238. Netherlands Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 239. Netherlands Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 240. Rest of Europe Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 241. Rest of Europe Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 242. Rest of Europe Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 243. Rest of Europe Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 244. MEA Marine Biomedicine, by Country USD Million (2021-2026)
  • Table 245. MEA Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 246. MEA Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 247. MEA Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 248. MEA Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 249. Middle East Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 250. Middle East Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 251. Middle East Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 252. Middle East Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 253. Africa Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 254. Africa Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 255. Africa Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 256. Africa Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 257. North America Marine Biomedicine, by Country USD Million (2021-2026)
  • Table 258. North America Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 259. North America Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 260. North America Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 261. North America Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 262. United States Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 263. United States Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 264. United States Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 265. United States Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 266. Canada Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 267. Canada Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 268. Canada Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 269. Canada Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 270. Mexico Marine Biomedicine, by Type USD Million (2021-2026)
  • Table 271. Mexico Marine Biomedicine, by Application USD Million (2021-2026)
  • Table 272. Mexico Marine Biomedicine, by Product USD Million (2021-2026)
  • Table 273. Mexico Marine Biomedicine, by Source USD Million (2021-2026)
  • Table 274. Research Programs/Design for This Report
  • Table 275. Key Data Information from Secondary Sources
  • Table 276. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Marine Biomedicine: by Type USD Million (2015-2020)
  • Figure 5. Global Marine Biomedicine: by Application USD Million (2015-2020)
  • Figure 6. Global Marine Biomedicine: by Product USD Million (2015-2020)
  • Figure 7. Global Marine Biomedicine: by Source USD Million (2015-2020)
  • Figure 8. South America Marine Biomedicine Share (%), by Country
  • Figure 9. Asia Pacific Marine Biomedicine Share (%), by Country
  • Figure 10. Europe Marine Biomedicine Share (%), by Country
  • Figure 11. MEA Marine Biomedicine Share (%), by Country
  • Figure 12. North America Marine Biomedicine Share (%), by Country
  • Figure 13. Global Marine Biomedicine share by Players 2020 (%)
  • Figure 14. Global Marine Biomedicine share by Players (Top 3) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Marinova (Australia) Revenue, Net Income and Gross profit
  • Figure 17. Marinova (Australia) Revenue: by Geography 2020
  • Figure 18. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 19. New England Biolabs (United States) Revenue: by Geography 2020
  • Figure 20. Seppic (France) Revenue, Net Income and Gross profit
  • Figure 21. Seppic (France) Revenue: by Geography 2020
  • Figure 22. GlycoMar (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. GlycoMar (United Kingdom) Revenue: by Geography 2020
  • Figure 24. Nofima (Norway) Revenue, Net Income and Gross profit
  • Figure 25. Nofima (Norway) Revenue: by Geography 2020
  • Figure 26. Aker BioMarine (Norway) Revenue, Net Income and Gross profit
  • Figure 27. Aker BioMarine (Norway) Revenue: by Geography 2020
  • Figure 28. Aquapharm (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Aquapharm (United Kingdom) Revenue: by Geography 2020
  • Figure 30. Global Marine Biomedicine: by Type USD Million (2021-2026)
  • Figure 31. Global Marine Biomedicine: by Application USD Million (2021-2026)
  • Figure 32. Global Marine Biomedicine: by Product USD Million (2021-2026)
  • Figure 33. Global Marine Biomedicine: by Source USD Million (2021-2026)
  • Figure 34. South America Marine Biomedicine Share (%), by Country
  • Figure 35. Asia Pacific Marine Biomedicine Share (%), by Country
  • Figure 36. Europe Marine Biomedicine Share (%), by Country
  • Figure 37. MEA Marine Biomedicine Share (%), by Country
  • Figure 38. North America Marine Biomedicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Marinova (Australia)
  • New England Biolabs (United States)
  • Seppic (France)
  • GlycoMar (United Kingdom)
  • Nofima (Norway)
  • Aker BioMarine (Norway)
  • Aquapharm (United Kingdom)
Select User Access Type

Key Highlights of Report


Feb 2021 244 Pages 52 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Marine Biomedicine Quantitative research analysis
Global Marine Biomedicine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Marine Biomedicine Report?

Have a Query? Click Here

Other Related Reports

Tipranavir Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Dosage (Oral Solution (100 mg/mL), Capsule (250 mg)) Players and Region - G...
$ 3500
Levocetirizine Drug Comprehensive Study by Type (Tablets, Oral Solution), Application (Allergic Rhinitis, Chronic Hives (Urticaria), Renal impairment, Hepatic impairment), Distribution Channel (Hospi...
$ 3450
Exenatide Comprehensive Study by Type (Extended-release injectable suspension, Fast release injectable suspension), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 20...
$ 3500
Varenicline Comprehensive Study by Type (0.5 mg Tablets, 1 mg Tablets), Application (Hospital Pharmacies, Drug store), Drugs (Prescription Drugs, OTC Drugs), Treatment Centres (Outpatient Treatment C...
$ 3450
Sleep Aid Supplements Comprehensive Study by Application (Pharmaceutical, Nutraceutical, Food and Beverage), Nature (Natural, Artificial), Sales Channel (Retail Stores, Medical Store, Convenience Sto...
$ 3450
Peptide Vaccine Comprehensive Study by Type (Biomarkers, NY-ESO-1), Application (Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others), Rout of Administration (Injec...
$ 3450